Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 1
2007 2
2008 5
2012 1
2013 2
2014 4
2015 10
2016 14
2017 22
2018 14
2019 10
2020 18
2021 18
2022 10
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Guardiola J, Jahnsen J, Lees C, Louis E, Lukáš M, Reinisch W, Roblin X, Jang M, Byun HG, Kim DH, Lee SJ, Atreya R. Peyrin-Biroulet L, et al. Among authors: kim dh. BMC Gastroenterol. 2022 Jun 8;22(1):291. doi: 10.1186/s12876-022-02347-1. BMC Gastroenterol. 2022. PMID: 35676620 Free PMC article.
Mycobacterium Tuberculosis in Spinal Tuberculosis.
Moon MS, Kim SS, Moon HL, Kim DH. Moon MS, et al. Among authors: kim dh. Asian Spine J. 2017 Feb;11(1):138-149. doi: 10.4184/asj.2017.11.1.138. Epub 2017 Feb 17. Asian Spine J. 2017. PMID: 28243382 Free PMC article. Review.
Combined Double-Pulley Remplissage and Bankart Repair.
Kim DH, Kim JY, Park J, Talwar M, Jenkins S, Gardner B, McGahan P, Chen JL. Kim DH, et al. Arthrosc Tech. 2022 Feb 18;11(3):e419-e425. doi: 10.1016/j.eats.2021.11.011. eCollection 2022 Mar. Arthrosc Tech. 2022. PMID: 35256986 Free PMC article.
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
D'Haens G, Reinisch W, Schreiber S, Cummings F, Irving PM, Ye BD, Kim DH, Yoon S, Ben-Horin S. D'Haens G, et al. Among authors: kim dh. Clin Drug Investig. 2023 Apr;43(4):277-288. doi: 10.1007/s40261-023-01252-z. Epub 2023 Apr 1. Clin Drug Investig. 2023. PMID: 37004656 Free PMC article. Clinical Trial.
Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.
Schreiber S, Ben-Horin S, Alten R, Westhovens R, Peyrin-Biroulet L, Danese S, Hibi T, Takeuchi K, Magro F, An Y, Kim DH, Yoon S, Reinisch W. Schreiber S, et al. Among authors: kim dh. Adv Ther. 2022 Jun;39(6):2342-2364. doi: 10.1007/s12325-021-01990-6. Epub 2022 Jan 6. Adv Ther. 2022. PMID: 34988877 Free PMC article. Review.
138 results